Table 1 Number of heteroplasmic SNVs per participant

From: Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality

Heteroplasmy count

Number of participants (%)

0

135,457 (69.5%)

1

47,008 (24.1%)

2

10,273 (5.3%)

3

1785 (0.92%)

4

280 (0.14%)

5

68 (0.03%)

Back to article page